TJO-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TJO-002, covering 2019-09-04 to 2019-09-04. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients [Phase 3]